Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo
$0.0001 0.00 (0.00%)
As of 11/12/2026 10:26 AM Eastern

About Acutus Medical Stock (NASDAQ:AFIB)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0140
Volume
195,070 shs
Average Volume
9,950 shs
Market Capitalization
$2.99 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acutus Medical, Inc. was a medical technology company focused on developing products for the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company’s technologies were designed for use by cardiac electrophysiologists during minimally invasive catheter-based procedures.

Its primary product platform was the AcQMap High Resolution Imaging and Mapping System, which combined ultrasound imaging with electrical mapping to create three-dimensional models of the heart and help physicians identify abnormal electrical activity. Acutus also developed related electrophysiology products, including mapping catheters and tools intended to support transseptal access and cardiac ablation procedures.

Founded in 2011 and headquartered in Carlsbad, California, Acutus served hospitals and electrophysiology centers in the United States and international markets, including Europe. The company later underwent significant restructuring, and Medtronic acquired certain Acutus assets and technologies. As a result, Acutus Medical is primarily of historical interest as an independent publicly traded company and developer of cardiac mapping technologies.

AI Generated. May Contain Errors.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFIB Stock News Headlines

Acutus Medical (AFIB) Set to Announce Quarterly Earnings on Friday
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
AFIB Acutus Medical, Inc. - Seeking Alpha
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical's stock was trading at $0.0002 at the start of the year. Since then, AFIB stock has decreased by 50.0% and is now trading at $0.0001.

Acutus Medical, Inc. (NASDAQ:AFIB) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.02. The business earned $4.60 million during the quarter, compared to the consensus estimate of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%.

Acutus Medical subsidiaries include Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Walt Disney (DIS), Moderna (MRNA), NVIDIA (NVDA), Shopify (SHOP), AMC Entertainment (AMC), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Today
11/13/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:AFIB
CIK
1522860
Employees
85
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%
Return on Equity
-311.64%
Return on Assets
-11.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.85
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$7.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
29,912,000
Free Float
28,228,000
Market Cap
$2.99 thousand
Optionable
No Data
Beta
5.96

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners